This S&P 500 Dividend Stock Could Be the Best Bad-News Buy on the Market
Two adages capture the dilemma investors face when they consider buying a beaten-down stock:
These well-known sayings seem to be contradictory. However, they're not when taken in the correct context. Some sinking stocks have poor underlying businesses and should be avoided -- just like a falling knife. Others have solid underlying businesses and are likely to rebound over time.
I think (NYSE: PFE) falls into the latter category. This S 500 dividend stock could be the best bad-news buy on the market.
Source Fool.com
Pfizer Inc. Aktie
26,63 €
-0,09 %
Die Community unterstützt Pfizer Inc. stark, mit vielen Buy- und wenigen Sell-Einschätzungen.
Eine Steigerung von über 50% ist für Pfizer Inc. möglich, angesichts eines Kursziels von 41 € gegenüber 26.63 €.
